Search Within

Timothy J Akhurst

  1. "Thoracic Oncology"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Department of Medicine (5)
  2. Solid Tumor Oncology Division (5)
  3. Thoracic Oncology (5)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Population Sciences Research Program (3)

More Groups

People
  1. Mark Kris (4)
  2. Bernard Park (3)
  3. Gabriel Plourde (3)
  4. Junting Zheng (3)
  5. Robert Downey (3)
  6. Ronglai Shen (3)

More People

Years
  1. 2016 (1)
  2. 2010 (1)
  3. 2009 (1)
  4. 2007 (1)
  5. 2006 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of Thoracic Surgery (1)
  3. Clinical Cancer Research (1)
  4. Journal of Thoracic Oncology (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of routine PET imaging to predict response and survival after induction therapy for non-small cell lung cancer
    Journal Article

    Barnett, S. A.; Downey, R. J.; Zheng, J.; Plourde, G.; Shen, R.; Chaft, J.; Akhurst, T.; Park, B. J.; Rusch, V. W.
    Annals of Thoracic Surgery (2016)

    Fulltext@MSK | Save
  • Use of PET-measured response in involved mediastinal lymph nodes to predict overall survival (OS) in non-small cell lung cancer (NSCLC) patients treated with induction therapy (IT) and surgery
    Meeting Abstract

    Barnett, S.; Plourde, G.; Zheng, J.; Pietanza, M.; Akhurst, T. J.; Downey, R. J.; Kris, M. G.; Shen, R.; Rusch, V. W.; Park, B. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • PET response and long term survival after resection of non-small cell lung cancer (NSCLC) following induction therapy (IT)
    Meeting Abstract

    Barnett, S. A.; Park, B. J.; Plourde, G.; Zheng, J. T.; Bains, M. S.; Downey, R. J.; Flores, R. M.; Rizk, N. P.; Shen, R. L.; Kris, M. G.; more...
    Journal of Thoracic Oncology (2009)

    Fulltext@MSK | Save
  • Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus
    Journal Article

    Riely, G. J.; Kris, M. G.; Zhao, B.; Akhurst, T.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Rizvi, N. A.; Schwartz, L. H.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Prospective FDG-PET and CT assessment of discontinuation of erlotinib (E) or gefitinib (G) in patients with EGFR TKI sensitive non-small cell lung cancer (NSCLC) who subsequently progress radiographically on E or G ("acquired resistance") followed by re-initiation of E or G and the subsequent addition of everolimus (RAD001)
    Meeting Abstract

    Riely, G. J.; Kris, M. G.; Schwartz, L. H.; Akhurst, T.; Zhao, B.; Milton, D. T.; Moore, E.; Tyson, L.; Pao, W.; Miller, V. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save